Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. Markets open in 2 hrs 49 mins

S&P Futures
5,868.00
-28.25(-0.48%)
Dow Futures
42,983.00
-194.00(-0.45%)
Nasdaq Futures
20,401.00
-118.50(-0.58%)
Russell 2000 Futures
2,237.70
-17.80(-0.79%)
Crude Oil
71.22
+0.66(+0.94%)
Gold
2,750.70
+11.80(+0.43%)

China SXT Pharmaceuticals, Inc. (SXTC)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD

Follow

Visitors trend2W10W9M

0.6794

+0.0493

(+7.82%)

At close: 04:00PM EDT

0.6895

+0.02

(+2.91%)

Pre-Market:

06:00AM EDT

Currency in USD

Valuation Measures⁴

Market Cap (intraday)	2.36M
Enterprise Value	-7.06M
Trailing P/E	12.51
Forward P/E	N/A
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	0.31
Price/Book (mrq)	0.17
Enterprise Value/Revenue	0.41
Enterprise Value/EBITDA	-0.36

Trading Information

Stock Price History

Beta (5Y Monthly)	1.14
52-Week Change ³	N/A
S&P500 52-Week Change ³	N/A
52 Week High ³	6.3900
52 Week Low ³	0.5300
50-Day Moving Average ³	0.7157
200-Day Moving Average ³	1.2687

Share Statistics

Avg Vol (3 month) ³	655.13k
Avg Vol (10 day) ³	462.53k
Shares Outstanding ⁵	3.48M
Implied Shares Outstanding ⁶	N/A
Float ⁸	3.47M
% Held by Insiders ¹	6.47%
% Held by Institutions ¹	2.11%
Shares Short (Sep 30, 2024) ⁴	251.56k
Short Ratio (Sep 30, 2024) ⁴	0.2
Short % of Float (Sep 30, 2024) ⁴	7.54%
Short % of Shares Outstanding (Sep 30, 2024) ⁴	7.24%
Shares Short (prior month Aug 30, 2024) ⁴	53.9k

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	N/A
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	1:4
Last Split Date ³	Feb 22, 2021

Financial Highlights

Fiscal Year

Fiscal Year Ends	Mar 31, 2024
Most Recent Quarter (mrq)	Mar 31, 2024

Profitability

Profit Margin	-160.67%
Operating Margin (ttm)	733.81%

Management Effectiveness

Return on Assets (ttm)	-4.97%
Return on Equity (ttm)	-21.65%

Income Statement

Revenue (ttm)	1.93M
Revenue Per Share (ttm)	2.22
Quarterly Revenue Growth (yoy)	29.50%
Gross Profit (ttm)	N/A
EBITDA	-1.89M
Net Income Avi to Common (ttm)	-3.1M
Diluted EPS (ttm)	-3.5700
Quarterly Earnings Growth (yoy)	N/A

Balance Sheet

Total Cash (mrq)	12.07M
Total Cash Per Share (mrq)	3.47
Total Debt (mrq)	3.7M
Total Debt/Equity (mrq)	26.52
Current Ratio (mrq)	1.60
Book Value Per Share (mrq)	6.28

Cash Flow Statement

Operating Cash Flow (ttm)	-1.93M
Levered Free Cash Flow (ttm)	-1.22M